Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 175 of 1,261

  1. US 11732025

    Anti-VEGF protein compositions and methods for producing the same

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  2. US 11730709

    Compositions and methods for treating severe pain

    Infirst Healthcare Limited · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  3. US 11730717

    Melanin-inspired antimicrobial

    THE BOARD OF REGENTS FOR THE OKLAHOMA AGRICULTURAL AND MECHANICAL COLLEGES · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  4. US 11730720

    ALK5 inhibitors

    Theravance Biopharma R&D IP, LLC · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  5. US 11730723

    Compounds and methods for treating viral infections

    LEXICON PHARMACEUTICALS, INC. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  6. US 11730740

    Laureth-4 containing topical formulations

    ARCUTIS BIOTHERAPEUTICS, INC. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  7. US 11732259

    Peptide oligonucleotide conjugates

    Sarepta Therapeutics, Inc. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  8. US 11731953

    Methods and compounds for restoring mutant p53 function

    PMV PHARMACEUTICALS, INC. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  9. US 11731986

    Inhibitors of low molecular weight protein tyrosine phosphatase (LMPTP) and uses thereof

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  10. US 11732005

    Peptidomimetic proteasome inhibitors

    Tri-Institutional Therapeutics Discovery Institute, Inc. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  11. US 11732007

    Therapeutic compounds and methods

    The Regents of the University of California · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  12. US 11732024

    VEGF antagonist formulations suitable for intravitreal administration

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  13. US 11730739

    Treatment of congenital adrenal hyperplasia

    Neurocrine Biosciences, Inc. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  14. US 11732037

    Weight loss regimen

    Boards of Regents, The University of Texas System · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  15. US 11732041

    Antibodies against 4G7-derived chimeric antigen receptors

    Allogene Therapeutics, Inc. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  16. US 11733191

    Closed-loop controlled chemical apparatus

    Government of the United States of America, as represented by the Secretary of Commerce · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  17. US 11732030

    Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  18. US 11732265

    Compositions and methods for modulating complement factor B expression

    Ionis Pharmaceuticals, Inc. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  19. US 11730799

    Cancer vaccines and methods of producing and using same

    THE UNITED STATES GOVERNMENT DEPARTMENT OF VETERANS AFFAIRS · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  20. US 11730775

    Methods for treatment of Clostridium difficile infection or recurrence or symptoms thereof

    Seres Therapeutics, Inc. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  21. US 11731966

    Compounds and their methods of use

    PRAXIS PRECISION MEDICINES, INC. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  22. US 11731099

    Method for controlling encapsulation efficiency and burst release of water soluble molecules from nanoparticles and microparticles produced by inverse flash nanoprecipitation

    THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  23. US 11730793

    Sustained release formulations using non-aqueous emulsions

    REGENERON PHARMACEUTICALS, INC. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

  24. US 11730741

    6-chromanol derivatives for use as a medicament

    Sulfateq B.V. · Granted Aug 22, 2023 · Expires Aug 17, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.